- Home
- AZ vs GOSS Comparison
AZ vs GOSS Comparison
Compare AZ & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZ
- GOSS
- Stock Information
- Founded
- AZ 2018
- GOSS 2015
- Country
- AZ Canada
- GOSS United States
- Employees
- AZ N/A
- GOSS N/A
- Industry
- AZ Industrial Machinery/Components
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- AZ Industrials
- GOSS Health Care
- Exchange
- AZ Nasdaq
- GOSS Nasdaq
- Market Cap
- AZ 220.4M
- GOSS 212.8M
- IPO Year
- AZ N/A
- GOSS 2019
- Fundamental
- Price
- AZ $7.38
- GOSS $1.40
- Analyst Decision
- AZ
- GOSS Strong Buy
- Analyst Count
- AZ 0
- GOSS 5
- Target Price
- AZ N/A
- GOSS $9.20
- AVG Volume (30 Days)
- AZ 140.4K
- GOSS 1.6M
- Earning Date
- AZ 04-02-2025
- GOSS 03-04-2025
- Dividend Yield
- AZ N/A
- GOSS N/A
- EPS Growth
- AZ N/A
- GOSS N/A
- EPS
- AZ N/A
- GOSS N/A
- Revenue
- AZ $6,628,000.00
- GOSS $105,322,000.00
- Revenue This Year
- AZ $30.95
- GOSS N/A
- Revenue Next Year
- AZ $646,436.00
- GOSS N/A
- P/E Ratio
- AZ N/A
- GOSS N/A
- Revenue Growth
- AZ N/A
- GOSS N/A
- 52 Week Low
- AZ $0.85
- GOSS $0.50
- 52 Week High
- AZ $7.80
- GOSS $1.60
- Technical
- Relative Strength Index (RSI)
- AZ 61.31
- GOSS 67.09
- Support Level
- AZ $6.44
- GOSS $1.37
- Resistance Level
- AZ $6.61
- GOSS $1.55
- Average True Range (ATR)
- AZ 0.43
- GOSS 0.13
- MACD
- AZ 0.06
- GOSS 0.03
- Stochastic Oscillator
- AZ 85.79
- GOSS 75.81
About AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.